JIMD Podcasts cover art

All Episodes

JIMD Podcasts — 276 episodes

#
Title
1

The Adult PKU brain: from phenylalanine exposure to brain aging

2

Research Round-Up: Sterols and Bile Acids

3

Beyond Metabolic Control: Optimising Nutrition in Inborn Errors of Protein Metabolism

4

Shortcast: Adult Refsum: Reducing Circulating Phytanic Acid Levels With Dietary Interventions

5

Hidden Disease or Uncertain Risk? Rethinking IMD Diagnosis and Newborn Screening

6

IMD Research Round-Up: Phenylketonuria

7

Rapamycin and Pharmacogenomics in Niemann-Pick C

8

Shortcast: Clinical Outcomes in Hydroxocobalamin-Treated Patients With Early-Onset Cobalamin C Disease

9

Feeding the Microbiome: Rethinking Protein and Propionate in MMA

10

Shortcast: Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB

11

High Glycine, Different Diagnoses

12

IMD Research Round-Up: Homocystinuria

13

Revisiting D-Bifunctional Protein Deficiency

14

Metabolic Mysteries: Two adult siblings with liver disease and haematological abnormalities

15

The Grey Zone in ABCD1 Variant Classification

16

Metabolic Mysteries: A 57-year-old man with vomiting and worsening confusion

17

Metabolic Mysteries: Recurrent abdominal pain, “FMF” and attacks around menstruation

18

Tyrosine Hydroxylase Deficiency: Consensus guidelines

19

Shortcast: Antenatal and Neonatal Management of Siblings With Carbonic Anhydrase VA Deficiency

20

D-Glyceric aciduria: is GLYCTK really mitochondrial?

21

Shortcast: Drivers of Diagnostic Delay in Mito Disease: Missed Recognition of Canonical Features

22

mRNA therapies in liver Inherited Metabolic Diseases

23

Shortcast: Epilepsy Phenotype and EEG Finding of RHADS in Succinate Dehydrogenase Deficiency

24

Beyond Triheptanoin: Elamipretide and Cardiolipin Remodelling in TFP Deficiency

25

Shortcast: Treatable Neonatal MoCD Type A: Rapid Demise Despite Rapid Biochemical Diagnosis

26

Personalized metabolic modeling in Methylmalonic Aciduria

27

Shortcast: Holocarboxylase Synthetase Deficiency: Second Case Report With Neonatal Cholestasis

28

Vitamin and Cofactor Prescribing in Primary Mitochondrial Disease

29

Shortcast: Fulminant Metabolic Crisis in GSDIa: Persistent Lactic Acidosis Despite Hypo Correction

30

Palliative care in inherited metabolic disease: an underutilised but essential service

31

Shortcast: A Multisystem Perspective of Pediatric Cell Trafficking Disorders: Within the Cells, Beneath the Signs

32

Manganese transporter disorders: diagnosis and treatment

33

Shortcast: Liver Directed Rx don’t change biochemistry nor Leukodystrophy in Biallelic HMBS Variants

34

Sixty Years of Metabolic Medicine: A Conversation with Jean-Marie Saudubray and Manuel Schiff

35

Continuous Glucose Monitoring in hepatic GSDs

36

Metabolic mysteries: Developmental delay, hepatoblastoma and a VUS

37

Biomarkers in Niemann-Pick type C: Preparing for Clinical Trials

38

Shortcast: Exploratory Study on the Challenges of Newborn Screening for Lysosomal Storage Disorders

39

Chenodeoxycholic acid in Cerebrotendinous Xanthomatosis

40

IMD Research Round-Up: Mitochondrial disease

41

First in human gene editing: a new era for IMD therapies

42

Metabolic mysteries: A 61-year-old with rhabdomyolysis and lifelong episodic fatigue

43

Geriatric IMD: Diagnosing inherited metabolic disorders in older adults

44

IMD Research Round-Up: Untargeted metabolomics

45

Pharmacological chaperones in OTC deficiency

46

Shortcast: Clinical and Developmental Outcomes after 50 Years of Galactosaemia NBS in Ireland

47

Penetrance, expressivity, and outcomes in classic galactosemia

48

IMD Research Round-Up: Lysosomal Storage Disorders

49

Adenosine Kinase

50

Footprints of IMD: Movement Disorders... with Dakota Peacock and Darius Ebrahimi-Fakhari

51

Metabolic mysteries: Incidental adrenal calcifications in a neonate

52

The treatment landscape in CDG

53

IMD Research Round-Up: Newborn Screening

54

ARS1 Deficiencies

55

Shortcast: Investigating the utility of leukocyte sialic acid measurements in Lysosomal FSASD

56

Diagnostic delay in Metachromatic Leukodystrophy

57

IMD Research Round-Up: Glycogen Storage Disorders

58

Future therapies in galactosemia

59

Metabolic mysteries: GI bleeding, gallbladder polyps and evolving developmental delay

60

Speech and Language in Batten disease

61

Metabolic Minds 2025

62

IMD Research Round-Up: Redox metabolism

63

ECHS1 deficiency and valine restriction

64

Metabolic mysteries: A child with episodic seizures and multiple diagnoses

65

Managing Metabolic Emergencies - Intoxication type disorders

66

IEMs in Adult Metabolic Centres: 10 Years Later

67

IMD Research Round-Up: Methylmalonic Aciduria

68

Shortcast: Sleep quality in children with hepatic GSDs, a prospective observational pilot study

69

NAXD deficiency

70

Imaging readiness in the gene therapy era

71

IMD Research Round-Up: Congenital Disorders of Glycosylation

72

Exploring the disease burden in Arginase 1 deficiency

73

Shortcast: D,L-3-hydroxybutyrate in the treatment of glucose transporter 1 deficiency syndrome (Glut1DS)

74

Citrulline: beyond the urea cycle

75

Metabolic mysteries: Hypoglycemia? Don't forget the urine

76

Metabolic mysteries: New weakness, poor balance and paresthesia at 55 years of age

77

Transition & executive function in MSUD

78

Shortcast: TFP deficiency caused by a deep intronic deletion leading to aberrant splicing

79

CBS Deficiency in the E-HOD Registry

80

The Treatabolome: Don't miss the chance to treat!

81

Velmanase alfa for alpha-mannosidosis

82

An update on autophagy disorders

83

Models in Leigh Syndrome

84

KAMPER: Kuvan (BH4) in phenylketonuria

85

Dietary management in GSD type 3a

86

Footprints of IMD: Psychiatric presentations... with Gabriella Horvath

87

Shortcast: Two successful pregnancies in patients taking Volanesorsen for FCS

88

RNA based therapies in Urea Cycle Disorders

89

Brain changes in infantile Pompe disease

90

Shortcast: Metabolic management of a successful pregnancy in FBPase deficiency

91

Gene therapy for mitochondrial disorders

92

Adult outcomes in classic galactosemia

93

Footprints of IMD: Metabolic cardiovascular disease... with Carlos Ferreira

94

Neuronopathic gaucher disease

95

Chorioretinopathy In LCHADD

96

Footprints of IMD: Metabolic myopathies... with Corrado Angelini

97

Flies, plants and classic galactosemia

98

Shortcast: Do early-treated adults with phenylketonuria sense high phenylalanine levels?

99

Fatty acid homeostasis

100

Metabolic mysteries: Progressive neurological symptoms after a change in diet

101

Heterozygous DHDDS variants

102

Footprints of IMD: Metabolic Epilepsies... with Phillip Pearl

103

Gene replacement therapies for inherited disorders of neurotransmission: Progress in SSADH

104

Shortcast: Galactokinase 1 is the source of elevated gal-1-phosphate in a galactosemia mouse model

105

Dietary management for pyridoxine-dependent epilepsy

106

Footprints of IMD: Metabolic Liver Disease... with David Cassiman

107

Shortcast: Normal transferrin glycosylation does not rule out severe ALG1 deficiency

108

Speech & neural oscillation in classic galactosemia

109

Shortcast: Late-onset refractory hemolytic anemia in siblings treated for MTRR deficiency

110

Lessons from adult metabolic medicine

111

Metabolic mysteries: A treatable condition masquerading as TORCH Infection

112

Footprints of IMD: the IEMbase and Cerebral Palsy... with Gabriella Horvath

113

Pregnancy in phenylketonuria

114

Acute liver failure? Think metabolic

115

Aicardi-Goutières syndrome

116

Shortcast: Pediatric palliative care for IMD: 20-year survey of outpatients at a Brazilian hospital

117

Pregnancy in Urea Cycle Disorders

118

Shortcast: Clinical experience with glycerol phenylbutyrate in 20 patients with UCDs

119

Liver directed gene therapy

120

Shortcast: Psychosocial issues and coping strategies in families affected by long-chain FAOD

121

BH4 in tyrosine hydroxylase deficiency

122

Shortcast: Lysinuric protein intolerance exhibiting RTA/Fanconi syndrome in a Japanese woman

123

How to proceed after a "negative" exome

124

Shortcast: Neuropsychological stability in classical galactosemia: A pilot study in 10 adults

125

Food or medicine? Nutritional therapies in IMD

126

Metabolic mysteries: Three children with neurological symptoms and coagulopathy

127

Movement disorders and mRNA therapy in Arginosuccinic aciduria

128

Metabolic mysteries: Recurrent miscarriage and congenital anomalies

129

Hepatic presentations in mitochondrial depletion syndromes

130

Shortcast: Lysosomal storage disorders identified in adult population from India

131

Genomic newborn screening: are we entering a new era of screening?

132

Shortcast: A case of hyperlysinemia identified by urine newborn screening

133

JIMD Editor's Roundtable (2023)

134

Shortcast: Relationship between plasma & capillary blood Phe using volumetric collection devices

135

Deciphering pathogenicity with CRISPR/Cas9

136

Shortcast: Grip strength in patients with galactosemia and in a GALT-null rat model

137

Gene therapy in Glycogen Storage Disorders

138

Shortcast: Screening data for 19 patients with late-onset Pompe disease for a phase I clinical trial

139

CAD deficiency: Beyond the genetics

140

Shortcast: Diagnosis and management of children with McArdle Syndrome (GSD V) in New South Wales

141

Shortcast: PIGO-CDG: A case study, phenotypic expansion, lit review, and nosological considerations

142

Comorbidity in acute porphyria

143

Metabolic mysteries: Post-partum ataxia and confusion

144

Shortcast: A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD

145

An oral enzyme therapy for MSUD

146

Shortcast: Comparison of subcutaneous and intravenous moss-aGal in Fabry disease mouse model

147

Metabolic mysteries: A child with dystonia and MRI changes

148

Fetal gene therapy

149

Shortcast: Interstitial lung disease and pancreatic exocrine insufficiency in CADDS

150

SSIEM 2022 special episode

151

Gene therapy in urea cycle disorders: a historical perspective and future prospects

152

Possible substrate reduction therapy in disorders of valine and isoleucine metabolism

153

Shortcast: Prolonged respiratory failure treatment in isolated homocysteine remethylation defects

154

A clinical severity scoring system for succinic semialdehyde dehydrogenase deficiency

155

Shortcast: Expanding the phenotypic and genotypic spectrum of CARS2-related mitochondrial disease

156

Pregnancy in acute porphyria

157

Gene therapies in mucopolysaccharidoses

158

Shortcast: Neonatal presentation of occipital horn syndrome caused by a ATP7A missense variant

159

Racial diversity and the S135L variant in galactosemia

160

Shortcast: Increased prevalence of Parkinson's disease in alkaptonuria

161

Shortcast: Late infantile & adult-onset MLD due to novel missense variants in the PSAP gene

162

Gene therapy in a mouse model of MSUD

163

Key terms and definitions In porphyria

164

PGM1-CDG: isoforms, phenotyping and gene therapy

165

A novel UHPLC/HRAM MS approach in LSD screening

166

Shortcast: Early treatment of neonatal diabetes with oral glibenclamide in extreme prematurity

167

Cholestasis, oxysterols and clinical conundrums

168

Shortcast: The remarkable journey of one female individual with OTC deficiency diagnosed post-mortem

169

Fractionated plasma N-glycan profiling and ATP6AP1 - CDG

170

Shortcast: Autonomic instability, arrhythmia & visual impairment in MTFMT related mito disease

171

B vitamins, drosophila and TANGO2-deficiency disorder

172

Shortcast: Paracetamol toxicity in classic HCU: Effect of N-acetylcysteine on total homocysteine

173

The complex machinery of cobalamin

174

Shortcast: MOGS-CDG: Quantitative analysis of a diagnostic biomarker & phenotype of 6 new cases

175

How guidelines drive research and research influences guidelines

176

Shortcast: Successful heart transplantation in an infant with phosphoglucomutase 1 deficiency

177

Shortcast: First decade anniversary of the United Kingdom National Alkaptonuria Centre

178

Cellular Insights and Computational Modelling In MMA

179

Novel therapy in a propionic acidemia mouse model

180

Shortcast: Compound heterozygous variants in 2 sialyltransferase ST3GAL5 motifs cause GM3SD

181

Shortcast: 3-Methylglutaconyl-CoA hydratase deficiency: Ascertainment bias vs biochemical diagnosis

182

Priority Setting Partnership in Mitochondrial Disease

183

Shortcast: HPMRS3 (Mabry Syndrome): CSF abnormalities and correction with pyridoxine & Folinic acid

184

Recommendations for diagnosing and managing individuals with glutaric aciduria type 1: 3rd revision

185

Diagnostics, EXPLORE B and POWER in Porphyria

186

Shortcast: Isolated neurological presentations of mevalonate kinase deficiency

187

Novel CSF biomarkers in GLUT1 deficiency syndrome

188

Shortcast: Management of pregnancy in a patient with LCHADD

189

Shortcast: Infantile-onset Pompe disease with neutropenia

190

Sex Specific Screening in X-linked Adrenoleucodystrophy

191

Shortcast: Direct replacement of oral benzoate with glycerol phenylbutyrate in children with UCD

192

Everyone's talking about empagliflozin

193

Shortcast: GA 1: Diagnosis, clinical features & long-term outcome in a cohort of 34 Irish patients

194

Shortcast: Use of Elamipretide in patients assigned treatment in the compassionate use program

195

Genomic Therapies In IMD: Lessons from MMA

196

Shortcast: Transcriptomic study in explanted liver from a patient with acute intermittent porphyria

197

Shortcast: Orofacial abnormalities in mucopolysaccharidosis and mucolipidosis type II and III

198

Moving towards management guidelines in ALG8 - CDG

199

Shortcast: Alternative sources of valine and isoleucine for prompt leucine reduction in MSUD

200

Shortcast: N-acetylglutamate synthase deficiency with associated 3-methylglutaconic aciduria

201

Eye movement disorders in Inherited Metabolic Disease

202

Shortcast: The prevalence of inherited metabolic disorders in the Estonian population over 30 years

203

Shortcast: Respiratory chain dysfunction in a patient with a heterozygous de novo CTBP1 variant

204

The doxycycline paradox in mitochondrial disease

205

Training in Adult Metabolic Medicine

206

Shortcast: A cross-sectional natural history study of aspartylglucosaminuria

207

Diagnosis and Discovery: Insights from the Undiagnosed Diseases Program

208

Future Therapies in Galactosaemia

209

Mitochondrial Trifunctional Protein Deficiency

210

Reproductive Genetic Carrier Screening in IMD

211

Glitazones in X-linked adrenoleukodystrophy

212

Betaine in early onset MTHFR Deficiency

213

Shortcast: Clinical spectrum of early onset “Mediterranean” MNGIE

214

Gls2 knockdown - a different approach for Urea Cycle Disorders?

215

Shortcast: Glycogen storage disease type IIIa in pregnant women

216

Lost in translation — Challenges in drug development for rare disease

217

Machine learning in newborn screening

218

Barth Syndrome (part 2): Screening, modelling and more

219

Barth Syndrome (part 1): Disease overview and future treatments

220

CDG or not CDG

221

Shortcast: High penetrance and recurrent attacks in a family with hereditary coproporphyria

222

Dentistry in Inherited Metabolic Disease

223

Shortcast: Very long-chain acyl-CoA dehydrogenase deficiency in a Swedish cohort

224

Shortcast: A serendipitous journey to a promoter variant in OTC

225

NGLY1 deficiency & epilepsy

226

Molybdenum Cofactor Deficiency

227

Shortcast: Chondroitin sulfate disaccharide as a biomarker for MPS IVA

228

Shortcast: A mild phenotype of mitochondrial trifunctional protein deficiency

229

Treatment In Alkaptonuria

230

Shortcast: Acute and early developmental outcomes of children with Duarte galactosemia

231

Arginase Deficiency

232

Shortcast: Two siblings with galactose mutarotase deficiency: Clinical differences

233

AAV-gene therapy in galactosemia patient fibroblasts

234

Unravelling the Secrets Of PMM2-CDG

235

Transplant Outcomes in X-ALD

236

Positive Negatives - genistein and resveratrol

237

100 Years Of IMD (in Austria)

238

Mitochondrial Disease Special Issue: Novel Therapies

239

Organoids in IMD

240

MPS 1: Where are we now?

241

Easy as ABC...D3

242

Assembling the treatment puzzle in Niemann Pick C

243

McArdle disease - expanding the clinical phenotype

244

Gene Therapy in CBS Deficiency

245

Cognitive and psychosocial outcomes in early-treated PKU

246

Disease Or Disorder: New Insights in Valine Degradation

247

Inborn Errors of the Malate Aspartate Shuttle

248

The Young Metabolists Society

249

Why everyone needs to know about Urea Cycle Disorders

250

Treatment In Lysosomal Storage Disorders

251

An International Classification of Inherited Metabolic Disorders

252

Emergency Protocol.net

253

N-glycome analysis in Congenital Disorders of Glycosylation

254

Galactosemia: An old diagnosis with new ideas

255

Diagnosis and management of methylmalonic acidaemia and propionic acidaemia

256

Transplantation in IMD

257

LSD Heterozygosity and Neurodegenerative Disease

258

Everything about Alkaptonuria

259

A narrative review of GSD III

260

ATP6V1A related metabolic cutis laxa

261

All About ALD

262

Pyridoxine-dependent epilepsy

263

Talking about Triheptanoin

264

It takes two to TANGO2

265

Characterising late-onset MTHFR deficiency

266

Best Of JIMD Reports

267

MSD: The diagnosis needs the patients

268

Taking a position on MNGIE

269

Newborn screening: To WES or not to WES

270

Ketogenic diets in inherited metabolic disease

271

Towards Trials in Mitochondrial Disease

272

PGM1-CDG with Professor Morava

273

Simplifying Inherited Metabolic Disease

274

IMD and Susceptibility to COVID19

275

Mitochondria, medication and POLG

276

PKU And Ageing